Apr 26, 2006 by Brian GormanWalgreen's ClinicsIn-store clinics could be more trouble than they're worth.
Apr 25, 2006 by Brian GormanPharma Plays With FireDrugmakers' short-term gain could lead to long-term pain.
Apr 24, 2006 by Brian GormanBelo's Unfolding StoryThe company is one of many struggling with newsprint and other expenses, but its revenue is growing.
Apr 21, 2006 by Brian GormanBoeing Looks Good at Home, TooThere's the Chinese market. But a strong relationship with a domestic carrier is worth close attention.
Apr 20, 2006 by Brian GormanBorgWarner's Going GreenBorgWarner's alliance with the EPA for cleaner diesel is both Earth-friendly and a shrewd business move.
Apr 19, 2006 by Brian GormanPfizer Inches ForwardThe phamra continues on cost-cutting and gives back to shareholders, but R&D productivity remains a tough challenge.
Apr 18, 2006 by Brian GormanPPD Develops Solid GrowthThe contract research firm cashes in on its core business.
Apr 17, 2006 by Brian GormanNovartis Presses on BiogenericsThe company wins a court case that could accelerate U.S. regulations for biogenerics.
Apr 13, 2006 by Brian GormanMonsanto's New ChallengeThe ag-biotech firm faces new competitive pressures from rivals and an ongoing wariness of GM crops in Europe.
Apr 5, 2006 by Brian GormanCBS's Couric Coup Overblown?Katie's move to CBS is generating headlines, but it may not be the smartest move from a business perspective.
Apr 4, 2006 by Brian GormanWal-Mart in Cultural CrossfireThe company faces protests for selling "Brokeback Mountain" DVDs.
Mar 31, 2006 by Brian GormanThe WB's Web CutThe federal crackdown on indecency may lead to opportunities for newer TV companies.
Mar 30, 2006 by Brian GormanChewing Gum Goes ScientificWrigley's scientific pursuits could provide it with valuable marketing claims.
Mar 29, 2006 by Brian GormanSugar HighsA tight supply situation for sugar has the potential to hit profits for a slew of food outfits.
Mar 28, 2006 by Brian GormanBoeing Overstretches?Boeing's decision to go ahead with a stretch 787 shouldn't be interpreted as a major positive.
Mar 27, 2006 by Brian GormanThe Greening of Wal-Mart?The company is hoping that its new focus on organic goods will help break down barriers to its expansion.
Mar 24, 2006 by Brian GormanCephalon Takes a HitThe FDA rules against its ADHD drug, but Cephalon's current lineup still holds promise.
Mar 23, 2006 by Brian GormanYahoo!'s Limited PartnershipThe Web giant's deal with "60 Minutes" is good news, but its potential impact shouldn't be overstated.
Mar 22, 2006 by Brian GormanSirius: Content Over ConvenienceIts agreement with VW and Audi suggests that the satellite radio firm has outmaneuvered rival XM.
Mar 21, 2006 by Brian GormanEthanol in the Crosshairs?Ethanol could face a political test in the coming months, with major implications for its producers.
